ConKay Medical Systems Secures $1.8M in Seed Funding
March 20, 2024, 9:35 am
ConKay Medical Systems, a medtech start-up from Pleasanton, CA, has successfully closed a $1.8M seed round. Investors like Unorthodox Ventures, SCP Ventures, and WS Investment Company joined in, along with individual angel investors. The company plans to use the funds to expand its operations and further develop its innovative device for treating valvular regurgitation. Led by Founder and CEO Albert Yuan, ConKay Medical Systems aims to provide solutions for patients with progressive heart failure. Their adjustable catheter addresses current limitations and avoids the need for pacemaker leads. Without the need for invasive chest surgery, the device offers a minimally invasive solution for patients. Albert Yuan expressed gratitude to investors for their support in advancing the company's mission to help patients live longer, healthier lives. The company looks forward to raising additional funds in the second quarter of 2024 to support First-in-Human testing.